'Radiopharmaceuticals market' presentation slideshows

Radiopharmaceuticals Market

Radiopharmaceutical is a radioactive pharmaceutical agent which is used diagnostic or therapeutic procedures. A radiopharmaceutical is made up of two components that are drug component and radioactive component.

247 views • 13 slides

Radiopharmaceuticals Market to be Driven at 18.3% CAGR by Increasing Incidence of Cancer

Studying the use of radiotracers for therapeutic purposes had begun immediately after the discovery of radioactivity, however, it was not until cyclotrons became available for the acceleration of particles to fabricate radioisotopes that a significant medical application of radiotracers came into being. Radioiodine, for instance, was introduced in 1946 for treating thyroid cancer, and remains till date the most effective method for the treatment of the condition as well as hyperthyroidism.

343 views • 12 slides

Radiopharmaceuticals Market projected to soar steadily at 5.9% CAGR, 2026

Widespread availability of SPECT and PET scanning machines will result in a growing number of radio diagnostic and radio therapeutics events in North America. For instance, the number of PET scanning machines installed per head of population in North America are more compared to that installed in Europe, thus leading to increased usage of radiotracers in the region. This growth in North America is expected to continue along with continuous technological improvements in PET scanning devices. The high level of awareness and accessibility to these machines is expected to account for high revenue generation in North America. This factor is boosting the overall growth of the global radiopharmaceuticals market. The other factor impacting the global radiopharmaceuticals market is the rising prevalence of cancer in North America. This has significantly increased the number of nuclear medicine procedures performed in the region and this is the precise reason that the market for radiopharmaceuticals is steadily growing in North America. There has been a rising number of cardiovascular diseases among the people in North America due to aging population, unhealthy food habits and rising obesity. The increasing number of cardiovascular patients is expected to boost the sales of radiopharmaceuticals, which would eventually create growth in the global radiopharmaceuticals market. Request Report Sample@ http://www.futuremarketinsights.com/reports/sample/rep-gb-1992

185 views • 11 slides

165 views • 11 slides

Nuclear Medicine/ Radiopharmaceuticals Market is Set to Boom by 2022

Nuclear Medicine/ Radiopharmaceuticals Market is expected to garner $8,207.5 million by 2022. The market is currently in its growth stage driven by increasing number of cancer cases and rising awareness about nuclear medicine.

205 views • 11 slides

Radiopharmaceuticals Market

Radiopharmaceutical is a radioactive pharmaceutical agent which is used diagnostic or therapeutic procedures. A radiopharmaceutical is made up of two components that are drug component and radioactive component.

180 views • 10 slides

Nuclear Medicine Market 2018 | Emerging Trends | Key Players

Radiopharmaceuticals is a medical specialty that uses specific radiotracers, and have emerged as an efficient imaging technology in the field of nuclear medicine. The non-invasive nature of radiopharmaceuticals has quickened the diagnosis of various diseases such as cardiovascular diseases, neurological disorders, and cancers.

142 views • 10 slides

Nuclear Medicine Market is expected to garner $8,207.5 million by 2022

This report provides an extensive analysis of the current and emerging market trends and dynamics in the global nuclear medicine market.This report includes a detailed quantitative analysis of the current market and estimations from 2014 to 2022, which contribute in identifying the key market opportunities for growth. Exhaustive analysis of the global radiopharmaceuticals market by type helps in understanding the types of radiopharmaceuticals that are currently being used along with the variants that would gain prominence in the future. Competitive intelligence (of leading manufacturers of radiopharmaceuticals) helps in understanding the competitive scenario across the geographies.

91 views • 8 slides

Nuclear Medicine Market is expected to garner $8,207.5 million by 2022

This report provides an extensive analysis of the current and emerging market trends and dynamics in the global nuclear medicine market.This report includes a detailed quantitative analysis of the current market and estimations from 2014 to 2022, which contribute in identifying the key market opportunities for growth. Exhaustive analysis of the global radiopharmaceuticals market by type helps in understanding the types of radiopharmaceuticals that are currently being used along with the variants that would gain prominence in the future. Competitive intelligence (of leading manufacturers of radiopharmaceuticals) helps in understanding the competitive scenario across the geographies.

98 views • 8 slides

Radiopharmaceuticals Market will register a CAGR of 5.9% through 2026

North America accounted for more than 40% market share in the global radiopharmaceuticals market in 2016 and is expected to witness an increase of more than 100 BPS in its market share over the forecast period. In terms of Y-o-Y growth, North America dominated the global radiopharmaceuticals market and was valued at more than US$ 2,000 Mn in 2015. The market is expected to expand at 6.2% CAGR over the projected period to reach more than US$ 4,000 Mn by the end of 2026. The North America radiopharmaceuticals market is estimated to represent absolute $ opportunity of more than US$ 100 Mn in 2017 over 2016. The growth is stagnant and slow due to major reactors having been shut down in Canada and new reactors installed in place of old ones for better production of radioisotope. North America is expected to be the most lucrative market in the global radiopharmaceuticals market, recording an attractiveness index of 3.6.

103 views • 8 slides

Radiopharmaceuticals Market to Display Growth at a CAGR of 5.9% by 2026

North America accounted for more than 40% market share in the global radiopharmaceuticals market in 2016 and is expected to witness an increase of more than 100 BPS in its market share over the forecast period. In terms of Y-o-Y growth, North America dominated the global radiopharmaceuticals market and was valued at more than US$ 2,000 Mn in 2015. The market is expected to expand at 6.2% CAGR over the projected period to reach more than US$ 4,000 Mn by the end of 2026. The North America radiopharmaceuticals market is estimated to represent absolute $ opportunity of more than US$ 100 Mn in 2017 over 2016. The growth is stagnant and slow due to major reactors having been shut down in Canada and new reactors installed in place of old ones for better production of radioisotope. North America is expected to be the most lucrative market in the global radiopharmaceuticals market, recording an attractiveness index of 3.6.

90 views • 8 slides

Nuclear Medicine Market is worth $5.55 Billion by 2017

Nuclear Medicine / Radiopharmaceuticals Market report segmented the global market by Applications (Cancer/Oncology, Cardiac), By Stable Isotopes (Deuterium, C-13), [SPECT/PET Radioisotopes (Technetium, F-18)]

308 views • 7 slides

Global Radiopharmaceuticals Market is Poised to Grow At 8.7% Till 2024

73 views • 5 slides

Global Radiopharmaceuticals Market is Poised to Grow At 8.7% Till 2024

63 views • 5 slides

Global Radiopharmaceuticals Market is Growing at a Significant Rate in the Forecast Period 2018-2025

73 views • 5 slides

Therapeutic Nuclear Medicines Market is Expected to Witness Significant Growth of 11.8% by 2028

55 views • 4 slides

Radiopharmaceuticals Market Size, Trend and Outlook 2026

52 views • 3 slides

Radiopharmaceuticals Market Scenario by Revenue, Drivers and Industry Dynamics by 2023

Global Radiopharmaceuticals Market Research Reports which includes Study of Growth, Regional Overview, Top participants, Major Drivers, Upcoming Trends and Forecast to 2023.

47 views • 3 slides

Radiopharmaceuticals Market - Revenues Worth US$7,430.8 million by 2024

Radiopharmacology is useful several branches of medicine including cardiology, nephrology, oncology, gastroenterology, immunology, and neurology. To know more about Radiopharmaceuticals Market , Please Visit : http://bit.ly/2G2o7La

16 views • 0 slides